Artikler med relevante resultater

fra vores forskning i øvrigt:

 

Prognostic utility of serum YKL-40 in patients with cervical cancer.

Roslind A, Palle C, Johansen JS, Christensen IJ, Nielsen HJ, Mosgaard BJ

Scandinavian journal of clinical and laboratory investigation (2020 Dec)
Issue 8 p. 687-693 issn:1502-7686)

 

Enhanced Performance of DNA Methylation Markers by Simultaneous Measurement of Sense and Antisense DNA Strands after Cytosine Conversion.

Jensen SØ, Øgaard N, Nielsen HJ, Bramsen JB, Andersen CL

Clinical chemistry (2020 May) (issn:1530-8561)

 

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer.

Tarpgaard LS, Ørum-Madsen MS, Christensen IJ, Nordgaard C, Noer J, Guren TK, Glimelius B, Sorbye H, Ikdahl T, Kure EH, Tveit KM, Nielsen HJ, Pfeiffer P, Brünner N, Moreira JM

Oncotarget (2016 Aug) (issn:1949-2553)

 

The prognostic and predictive value of soluble of type IV collagen in colorectal cancer: A retrospective multicenter study.

Rolff HC, Christensen IJ, Vainer B, Svendsen LB, Loevendahl Eefsen R, Wilhelmsen M, Lund IK, Hoyer-Hansen G, Nielsen HJ, Illemann M.

Clin Cancer Res. 2015 Dec 16. pii: clincanres.2342.2015. [Epub ahead of print]

 

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab.

Tarpgaard LS, Christensen IJ, Høyer-Hansen G, Lund IK, Guren TK, Glimelius B, Sorbye H, Tveit KM, Nielsen HJ, Moreira JM, Pfeiffer P, Brünner N.

Int J Cancer. 2015 Nov 15;137(10):2470-7. doi: 10.1002/ijc.29476. Epub 2015 Mar 9.

 

Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma.

Holck S, Nielsen HJ, Pedersen N, Larsson LI.

Oncotarget. 2015 Oct 27;6(33):34321-8. doi: 10.18632/oncotarget.5761.

 

Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.

Sønderstrup IM, Nygård SB, Poulsen TS, Linnemann D, Stenvang J, Nielsen HJ, Bartek J, Brünner N, Nørgaard P,
Riis L.

Mol Oncol. 2015 Jun;9(6):1207-17. doi: 10.1016/j.molonc.2015.02.009. Epub 2015 Mar 4.

 

TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.

Spindler KL, Christensen IJ, Nielsen HJ, Jakobsen A, Brünner N.

Tumour Biol. 2015 Jun;36(6):4301-8. doi: 10.1007/s13277-015-3069-z. Epub 2015 Jan 23.

 

IQGAP1 in rectal adenocarcinomas: localization and protein expression before and after radiochemotherapy.

Holck S, Nielsen HJ, Hammer E, Christensen IJ, Larsson LI.

Cancer Lett. 2015 Jan 28;356(2 Pt B):556-60. doi: 10.1016/j.canlet.2014.10.005. Epub 2014 Oct 8.

 

Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients.

Vižin T, Christensen IJ, Wilhelmsen M, Nielsen HJ, Kos J.

BMC Cancer. 2014 Apr 13;14:259. doi: 10.1186/1471-2407-14-259.